Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceutical Chemicals

EuroAPI to boost pain relief API supply for France

by Rick Mullin
July 9, 2023 | A version of this story appeared in Volume 101, Issue 22

 

EuroAPI’s controlled substance division, Francopia, will invest up to $76 million in a project to boost production of pain relief active pharmaceutical ingredients (APIs) at its plant in Vertolaye, France. The investment aims at increasing domestic production of morphine and its derivatives, as well as their antagonists used as antidotes, by 2027. Research goals, backed by 15% of the investment, include developing a production process that could increase productivity by 20–30%. The process is also expected to improve solvent recycling and reduce energy consumption. The project, funded in part by the French government, also includes production technology upgrades targeting a 15–20% capacity increase.

Article:

This article has been sent to the following recipient:

1 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.